Business Context and Reporting Period
This Form 8-K filing by Targacept, Inc. (not Gyre Therapeutics, Inc.) reports on the results of the 2011 Annual Meeting of Stockholders held on June 8, 2011. The filing details the outcomes of four specific matters submitted to a vote by security holders.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Voting Results
The following matters were approved or ratified by stockholders:
- Election of Directors: M. James Barrett, Julia R. Brown, J. Donald deBethizy, and John P. Richard were elected as Class II directors for a term expiring in 2014. All nominees received overwhelming support with over 21.4 million shares voted "For" each.
- Advisory Vote on Executive Compensation: Stockholders approved the compensation of named executive officers on an advisory basis. Approximately 21.36 million shares voted "For" versus 124,119 "Against."
- Frequency of Future Advisory Votes: Stockholders recommended an annual frequency (1 year) for future advisory votes on executive compensation. Approximately 18.66 million shares voted for a 1-year frequency.
- Ratification of Auditor: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2011, was ratified. Approximately 24.46 million shares voted "For."
Guidance, Outlook, and Risks
The filing states that the Company intends to include an advisory vote on executive compensation in proxy materials for each annual meeting until the next advisory vote on frequency, which will occur no later than the 2017 annual meeting. No specific business risks, contingencies, or unusual items are disclosed in this report.
Investor Verification Checklist
- Verify the company name is Targacept, Inc. (the input metadata incorrectly listed Gyre Therapeutics, Inc.).
- Confirm the election of the four Class II directors for the 2011-2014 term.
- Note the stockholder preference for annual executive compensation advisory votes.
- Review the definitive proxy statement filed on April 21, 2011, for detailed descriptions of the matters voted upon.